- Associated Press - Wednesday, October 19, 2011

OKLAHOMA CITY (AP) — An Oklahoma judge on Wednesday temporarily blocked from taking effect a new law designed to reduce the number of abortions performed in the state by restricting the ways in which doctors can treat women with abortion-inducing drugs.

Oklahoma County District Judge Daniel Owens issued the ruling after a conference call with lawyers for both sides.

The temporary injunction prevents the bill from going into effect Nov. 1. Passed earlier this year by the GOP-controlled Legislature and signed by Gov. Mary Fallin, a Republican, the measure requires doctors to follow the strict guidelines and protocols authorized by the U.S. Food and Drug Administration and prohibits off-label uses of the drugs. It also requires doctors to examine the woman, document certain medical conditions and schedule a follow-up appointment.

Opponents of the measure say the off-label use of drugs — such as changing a recommended dosage or prescribing it for different symptoms than the drug initially was approved for — is common and that the measure would prevent doctors from using their best medical judgment.


“We’re thrilled that women in Oklahoma will continue to be able to access medical care that accounts for scientific evidence, sound medical judgment and advancements in medicine,” said Michelle Movahed, a lawyer for the New York-based Center for Reproductive Rights, which challenged the law on behalf of Nova Health Systems, a Tulsa-based abortion provider, and the Oklahoma Coalition for Reproductive Justice, a nonprofit abortion-rights group.

Similar laws approved in North Dakota and Ohio have been delayed pending legal challenges, Ms. Movahed said. The North Dakota lawsuit says that state’s law would prevent doctors from using the drug misoprostol because it’s labeled for treatment of stomach ulcers. It’s one of two drugs that are administered in combination to induce abortions.

Lawyers for Oklahoma contend that the drugs are dangerous and should be used only in strict accordance with FDA guidelines.

“To date, at least eight American women have died from mifepristone abortions,” Assistant Attorney General Victoria Tindall wrote in the state’s response to the center’s lawsuit. “The dangerous risks of mifepristone demand strict adherence to the FDA-approved protocol.”

Ms. Tindall declined to discuss the case after a hearing Tuesday, and the attorney general’s office did not immediately respond to a request for comment Wednesday.

Ms. Movahed said as many as 21 percent of all drugs are prescribed for off-label use. In the case of drug-induced abortions, she said a common regimen is to use one-third of the FDA-recommended amount of the abortion drug mifepristone in conjunction with misoprostol, which has been determined to be effective for a variety of other purposes than gastric ulcers. She said that in the decade since the mifepristone FDA label was approved, numerous studies have shown that the combination is safer and more effective.

“The evidence supporting these alternative regimens are of such high quality that the American College of Obstetricians and Gynecologists gave these alternative regiments their highest possible recommendation,” Ms. Movahed said.

Ms. Movahed also disputed the state’s assertion that abortion drugs caused the deaths of women.

“Those cases were investigated by both the FDA and the (Centers for Disease Control and Prevention), and there was absolutely no causal relationship found between those unfortunate deaths and the medications that had been used,” she said.

The author of the Oklahoma measure, state Rep. Randy Grau, who is a Republican, has said previously that the goal of the bill is to promote patient safety and that any claim that it would make women less safe “is just ridiculous.” He did not immediately return a telephone message Wednesday.

Oklahoma also passed a law last year that would require women seeking abortions first to have an ultrasound and listen to a detailed description of the fetus. The Center for Reproductive Rights also is challenging that law, which has been temporarily suspended while the case is ongoing.

Story Continues →